vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and TIC Solutions, Inc. (TIC). Click either name above to swap in a different company.

TIC Solutions, Inc. is the larger business by last-quarter revenue ($508.3M vs $487.7M, roughly 1.0× CLOVER HEALTH INVESTMENTS, CORP.). TIC Solutions, Inc. runs the higher net margin — -9.3% vs -10.1%, a 0.8% gap on every dollar of revenue. TIC Solutions, Inc. produced more free cash flow last quarter ($37.1M vs $-69.0M).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

CLOV vs TIC — Head-to-Head

Bigger by revenue
TIC
TIC
1.0× larger
TIC
$508.3M
$487.7M
CLOV
Higher net margin
TIC
TIC
0.8% more per $
TIC
-9.3%
-10.1%
CLOV
More free cash flow
TIC
TIC
$106.1M more FCF
TIC
$37.1M
$-69.0M
CLOV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
TIC
TIC
Revenue
$487.7M
$508.3M
Net Profit
$-49.3M
$-47.2M
Gross Margin
35.2%
Operating Margin
-10.1%
-3.8%
Net Margin
-10.1%
-9.3%
Revenue YoY
44.7%
Net Profit YoY
-123.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
TIC
TIC
Q4 25
$487.7M
$508.3M
Q3 25
$496.6M
$473.9M
Q2 25
$477.6M
$313.9M
Q1 25
$462.3M
$234.2M
Q4 24
$337.0M
Q3 24
$331.0M
Q2 24
$356.3M
Q1 24
$346.9M
Net Profit
CLOV
CLOV
TIC
TIC
Q4 25
$-49.3M
$-47.2M
Q3 25
$-24.4M
$-13.9M
Q2 25
$-10.6M
$-233.0K
Q1 25
$-1.3M
$-25.8M
Q4 24
$-22.1M
Q3 24
$-9.2M
Q2 24
$7.4M
Q1 24
$-19.2M
Gross Margin
CLOV
CLOV
TIC
TIC
Q4 25
35.2%
Q3 25
32.2%
Q2 25
23.6%
Q1 25
18.6%
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
TIC
TIC
Q4 25
-10.1%
-3.8%
Q3 25
-4.9%
-1.4%
Q2 25
-2.2%
5.8%
Q1 25
-0.3%
-4.0%
Q4 24
-6.4%
Q3 24
-2.7%
Q2 24
2.0%
Q1 24
-6.5%
Net Margin
CLOV
CLOV
TIC
TIC
Q4 25
-10.1%
-9.3%
Q3 25
-4.9%
-2.9%
Q2 25
-2.2%
-0.1%
Q1 25
-0.3%
-11.0%
Q4 24
-6.6%
Q3 24
-2.8%
Q2 24
2.1%
Q1 24
-5.5%
EPS (diluted)
CLOV
CLOV
TIC
TIC
Q4 25
Q3 25
$-0.08
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
TIC
TIC
Cash + ST InvestmentsLiquidity on hand
$78.3M
$439.5M
Total DebtLower is stronger
$1.6B
Stockholders' EquityBook value
$308.7M
$2.2B
Total Assets
$541.0M
$4.4B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
TIC
TIC
Q4 25
$78.3M
$439.5M
Q3 25
$164.4M
Q2 25
$130.1M
Q1 25
$155.7M
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Q1 24
$208.3M
Total Debt
CLOV
CLOV
TIC
TIC
Q4 25
$1.6B
Q3 25
$1.6B
Q2 25
$751.3M
Q1 25
$752.4M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
TIC
TIC
Q4 25
$308.7M
$2.2B
Q3 25
$340.9M
$2.0B
Q2 25
$344.2M
$1.2B
Q1 25
$336.1M
$1.1B
Q4 24
$341.1M
Q3 24
$342.2M
Q2 24
$324.9M
Q1 24
$292.5M
Total Assets
CLOV
CLOV
TIC
TIC
Q4 25
$541.0M
$4.4B
Q3 25
$559.7M
$4.2B
Q2 25
$575.0M
$2.2B
Q1 25
$583.7M
$2.2B
Q4 24
$580.7M
Q3 24
$653.0M
Q2 24
$674.2M
Q1 24
$671.8M
Debt / Equity
CLOV
CLOV
TIC
TIC
Q4 25
0.74×
Q3 25
0.83×
Q2 25
0.64×
Q1 25
0.67×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
TIC
TIC
Operating Cash FlowLast quarter
$-66.9M
$49.7M
Free Cash FlowOCF − Capex
$-69.0M
$37.1M
FCF MarginFCF / Revenue
-14.1%
7.3%
Capex IntensityCapex / Revenue
0.4%
2.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$61.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
TIC
TIC
Q4 25
$-66.9M
$49.7M
Q3 25
$12.1M
$19.0M
Q2 25
$5.4M
$-6.5M
Q1 25
$-16.3M
$32.8M
Q4 24
$34.8M
Q3 24
$50.0M
Q2 24
$44.8M
Q1 24
$25.9M
Free Cash Flow
CLOV
CLOV
TIC
TIC
Q4 25
$-69.0M
$37.1M
Q3 25
$11.4M
$10.3M
Q2 25
$4.8M
$-14.5M
Q1 25
$-16.5M
$28.3M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
Q1 24
$25.5M
FCF Margin
CLOV
CLOV
TIC
TIC
Q4 25
-14.1%
7.3%
Q3 25
2.3%
2.2%
Q2 25
1.0%
-4.6%
Q1 25
-3.6%
12.1%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
Q1 24
7.3%
Capex Intensity
CLOV
CLOV
TIC
TIC
Q4 25
0.4%
2.5%
Q3 25
0.1%
1.8%
Q2 25
0.1%
2.6%
Q1 25
0.0%
1.9%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
CLOV
CLOV
TIC
TIC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

TIC
TIC

Consulting Engineering Segment$300.1M59%
Geospatial Segment$131.3M26%
Fixed Unit Price Contracts$54.3M11%
Other$22.6M4%

Related Comparisons